blu research suggests potential breakthrough in future e-liquid classifications

(Imperial Brands) A new study by Imperial Brands, owners of vape brand blu, suggests that Genomic Allergen Rapid Detection (GARD) in-vitro assays can be used to differentiate and classify vape e-liquids, as well as detect allergens potentially present in ingredients. These assays were originally developed to assess the sensitisation potential of compounds in the chemical manufacturing industry, but this pioneering research is the first vaping-related application and demonstrates the potential to raise product standards in this area.
Source: EurekAlert! - Social and Behavioral Science - Category: International Medicine & Public Health Source Type: news